RaQualia Pharma Inc
TSE:4579

Watchlist Manager
RaQualia Pharma Inc Logo
RaQualia Pharma Inc
TSE:4579
Watchlist
Price: 972 JPY -3.76% Market Closed
Market Cap: 23.8B JPY

RaQualia Pharma Inc
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

RaQualia Pharma Inc
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
RaQualia Pharma Inc
TSE:4579
EPS (Diluted)
-ÂĄ29
CAGR 3-Years
N/A
CAGR 5-Years
-31%
CAGR 10-Years
14%
Takeda Pharmaceutical Co Ltd
TSE:4502
EPS (Diluted)
ÂĄ20
CAGR 3-Years
-46%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Daiichi Sankyo Co Ltd
TSE:4568
EPS (Diluted)
ÂĄ151
CAGR 3-Years
67%
CAGR 5-Years
20%
CAGR 10-Years
-11%
Otsuka Holdings Co Ltd
TSE:4578
EPS (Diluted)
ÂĄ850
CAGR 3-Years
61%
CAGR 5-Years
26%
CAGR 10-Years
12%
Chugai Pharmaceutical Co Ltd
TSE:4519
EPS (Diluted)
ÂĄ241
CAGR 3-Years
-12%
CAGR 5-Years
14%
CAGR 10-Years
21%
Astellas Pharma Inc
TSE:4503
EPS (Diluted)
ÂĄ69
CAGR 3-Years
-5%
CAGR 5-Years
-1%
CAGR 10-Years
-1%
No Stocks Found

RaQualia Pharma Inc
Glance View

Market Cap
23.8B JPY
Industry
Pharmaceuticals

RaQualia Pharma, Inc. engages in a research and development of pharmaceuticals. The company is headquartered in Nagoya, Aichi-Ken and currently employs 67 full-time employees. The company went IPO on 2011-07-20. The firm is mainly engaged in the discovery and research, the preclinical trials and part of clinical trials of drugs, as well as the licensing of developed compounds to pharmaceutical companies. The firm is focused on pain diseases area and intestinal disease area. Its products include EP4 antagonist, cyclooxygenase-2 (COX-2) inhibitory, 5-HT4 portion partial agonist, among others.

Intrinsic Value
708.16 JPY
Overvaluation 27%
Intrinsic Value
Price

See Also

What is RaQualia Pharma Inc's EPS (Diluted)?
EPS (Diluted)
-29.6 JPY

Based on the financial report for Sep 30, 2025, RaQualia Pharma Inc's EPS (Diluted) amounts to -29.6 JPY.

What is RaQualia Pharma Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
14%

Over the last year, the EPS (Diluted) growth was -17%.

Back to Top